Ballentine Partners’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,062
| Closed | -$174K | – | 926 |
|
|
2024
Q4 | $174K | Sell |
10,062
-39
| -0.4% | -$675 | ﹤0.01% | 800 |
|
|
2024
Q3 | $187K | Sell |
10,101
-29
| -0.3% | -$537 | ﹤0.01% | 757 |
|
|
2024
Q2 | $206K | Buy |
+10,130
| New | +$206K | ﹤0.01% | 687 |
|
|
2024
Q1 | – | Sell |
-16,334
| Closed | -$288K | – | 744 |
|
|
2023
Q4 | $288K | Buy |
+16,334
| New | +$288K | 0.01% | 512 |
|
|
2017
Q1 | – | Sell |
-2,461
| Closed | -$282K | – | 256 |
|
|
2016
Q4 | $282K | Buy |
2,461
+556
| +29% | +$63.7K | 0.02% | 155 |
|
|
2016
Q3 | $214K | Hold |
1,905
| – | – | 0.02% | 170 |
|
|
2016
Q2 | $237K | Sell |
1,905
-100
| -5% | -$12.4K | 0.02% | 177 |
|
|
2016
Q1 | $225K | Buy |
+2,005
| New | +$225K | 0.02% | 181 |
|